In contrast, dedifferentiation events caused by the treatment of bulk cancer cells with chemotherapy seem to utilize not only the SOX2 and OCT3/4 pathways 65, but also stemness genes and CSC markers such as notch and ALDH1 66. This evidence concerns the gene SOX2 and cancer.